Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 2/2007

01-02-2007 | Letter to the Editor

GTX do play a role, but the relevance needs to be defined yet!

Author: Lorenz Grigull

Published in: Supportive Care in Cancer | Issue 2/2007

Login to get access

Excerpt

Cesaro and colleagues report on the difficulties of treating a child with an invasive fusariosis in the context of severe and prolonged neutropenia. This case report underscores the therapeutic benefit of granulocyte-colony stimulation factor (G-CSF)-mobilized granulocyte transfusions (GTX) in certain scenarios. …
Literature
1.
Hubel K, Carter RA, Liles WC, Dale DC, Price TH, Bowden RA, Rowley SD, Chauncey TR, Bensinger WI, Boeckh M (2002) Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors. Transfusion 42(11):1414–1421PubMedCrossRef
2.
Ganguly S, Carrum G, Nizzi F, Heslop HE, Popat U (2004) Transfusion-related acute lung injury (TRALI) following allogeneic stem cell transplant for acute myeloid leukemia. Am J Hematol 75:48–51PubMedCrossRef
3.
Metadata
Title
GTX do play a role, but the relevance needs to be defined yet!
Author
Lorenz Grigull
Publication date
01-02-2007
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 2/2007
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-006-0155-1

Other articles of this Issue 2/2007

Supportive Care in Cancer 2/2007 Go to the issue

Review Article

Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infection

Original Article

Hospice at Home service: the carer’s perspective

Original Article

Fluctuating awareness of treatment goals among patients and their caregivers: a longitudinal study of a dynamic process

Original Article

Evaluation of a 12-week home-based walking intervention for breast cancer survivors

Forthcoming Meetings

Forthcoming Meetings

Original Article

The impact of chemotherapy-induced nausea and vomiting on health-related quality of life
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits